As of 2025-07-22, the Relative Valuation of Vascular Biogenics Ltd (VBLT) is (4.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.16 USD, the upside of Vascular Biogenics Ltd based on Relative Valuation is -2879.5%.
The range of the Relative Valuation is (3.61) - (4.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 21.7x | 20.4x |
| Forward P/E multiples | 17.6x - 22.0x | 21.8x |
| Fair Price | (3.61) - (4.45) | (4.34) |
| Upside | -2413.2% - -2953.3% | -2879.5% |
| Date | P/E |